Funding for this research was provided by:
U.S. Army Materiel Command (W81XWH-15-1-0414)
National Institute of Neurological Disorders and Stroke (NS109540)
Received: 19 August 2019
Accepted: 29 December 2019
First Online: 6 January 2020
Ethics approval and consent to participate
: This study of using patient-derived iPSCs was determined as not human subjects research by the Institutional Review Board.
: Not applicable
: SJH is a member of the scientific advisory boards of Frequency Therapeutics, Psy Therapeutics, and Souvien Therapeutics, none of who were involved in this study. SDS is a scientific advisor for Outermost Therapeutics, Inc., which played no part in the present study. The other authors declare no competing interests.